Crossmark

ASO Author Reflections: Epidural Analgesia Decreases In-Hospital Mortality, Respiratory Complications, and Anastomotic Leakage After Minimally Invasive Esophagectomy for Esophageal Cancer

Crossref DOI link: https://doi.org/10.1245/s10434-022-12431-1

Published Online: 2022-08-27

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hirano, Yuki https://orcid.org/0000-0002-3976-2278
Kaneko, Hidehiro

Konishi, Takaaki

Itoh, Hidetaka

Matsuda, Satoru

Kawakubo, Hirofumi

Daiko, Hiroyuki

Itano, Osamu

Yasunaga, Hideo

Kitagawa, Yuko
Funding

Funding for this research was provided by:

Ministry of Health, Labour and Welfare (20AA2005, 21AA2007)

Ministry of Education, Culture, Sports, Science and Technology (20H03907)
License Information

Text and Data Mining valid from 2022-08-27

Version of Record valid from 2022-08-27
More Information

Article History

Received: 4 August 2022

Accepted: 5 August 2022

First Online: 27 August 2022

Disclosures

: Dr. Kitagawa has received grants and personal fees from Asahi Kasei Pharma Corporation, grants, personal fees and others from Ono Pharmaceutical Co. Ltd., grants and personal fees from Otsuka Pharmaceutical Factory Inc., grants and personal fees from Nippon Covidien Inc., grants, personal fees and others from Taiho Pharmaceutical Co. Ltd., grants, personal fees and others from Chugai Pharmaceutical Co. Ltd., grants and personal fees from Kaken Pharmaceutical Co. Ltd., personal fees from AstraZeneca K.K., personal fees from Ethicon Inc., personal fees from Olympus Corporation, personal fees from Shionogi & Co. Ltd., personal fees and others from Bristol-Myers Squibb K.K., personal fees from MSD K.K., personal fees from Smith & Nephew K.K., personal fees from Aska Pharmaceutical Co. Ltd., personal fees from Miyarisan Pharmaceutical Co. Ltd., personal fees from Toray Industries, Inc., personal fees from Daiichi Sankyo Co. Ltd., personal fees from Chugai Foundation for Innovative Drug Discovery Science, personal fees from Nippon Kayaku Co. Ltd., grants from Yakult Honsha Co. Ltd., grants from Otsuka Pharmaceutical Co. Ltd., grants from Tsumura & Co., grants from Sumitomo Pharma Co. Ltd., grants from EA Pharma Co. Ltd., grants from Eisai Co. Ltd., grants from Kyouwa Hakkou Kirin Co. Ltd., grants from Medicon Inc., grants from Takeda Pharmaceutical Co. Ltd., and grants from Teijin Pharma Ltd. outside the submitted work. No other disclosures are reported.

Document is current

Any future updates will be listed below